Research ArticleBasic Science Investigations
Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents
Deepti Soodgupta, Haiying Zhou, Wissam Beaino, Lan Lu, Michael Rettig, Mark Snee, James Skeath, John F. DiPersio, Walter J. Akers, Richard Laforest, Carolyn J. Anderson, Michael H. Tomasson and Monica Shokeen
Journal of Nuclear Medicine April 2016, 57 (4) 640-645; DOI: https://doi.org/10.2967/jnumed.115.164624
Deepti Soodgupta
1Division of Oncology, Department of Medicine, Washington University Medical School, St. Louis, Missouri
Haiying Zhou
2Mallinckrodt Institute of Radiology, Washington University Medical School, St. Louis, Missouri
Wissam Beaino
3Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania; and
Lan Lu
1Division of Oncology, Department of Medicine, Washington University Medical School, St. Louis, Missouri
Michael Rettig
1Division of Oncology, Department of Medicine, Washington University Medical School, St. Louis, Missouri
Mark Snee
4Department of Genetics, Washington University Medical School, St. Louis, Missouri
James Skeath
4Department of Genetics, Washington University Medical School, St. Louis, Missouri
John F. DiPersio
1Division of Oncology, Department of Medicine, Washington University Medical School, St. Louis, Missouri
Walter J. Akers
2Mallinckrodt Institute of Radiology, Washington University Medical School, St. Louis, Missouri
Richard Laforest
2Mallinckrodt Institute of Radiology, Washington University Medical School, St. Louis, Missouri
Carolyn J. Anderson
3Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania; and
Michael H. Tomasson
1Division of Oncology, Department of Medicine, Washington University Medical School, St. Louis, Missouri
Monica Shokeen
2Mallinckrodt Institute of Radiology, Washington University Medical School, St. Louis, Missouri
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 4
April 1, 2016
Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents
Deepti Soodgupta, Haiying Zhou, Wissam Beaino, Lan Lu, Michael Rettig, Mark Snee, James Skeath, John F. DiPersio, Walter J. Akers, Richard Laforest, Carolyn J. Anderson, Michael H. Tomasson, Monica Shokeen
Journal of Nuclear Medicine Apr 2016, 57 (4) 640-645; DOI: 10.2967/jnumed.115.164624
Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents
Deepti Soodgupta, Haiying Zhou, Wissam Beaino, Lan Lu, Michael Rettig, Mark Snee, James Skeath, John F. DiPersio, Walter J. Akers, Richard Laforest, Carolyn J. Anderson, Michael H. Tomasson, Monica Shokeen
Journal of Nuclear Medicine Apr 2016, 57 (4) 640-645; DOI: 10.2967/jnumed.115.164624
Jump to section
Related Articles
Cited By...
- First-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging
- Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury
- VLA-4 phosphorylation during tumor and immune cell migration relies on its coupling to VEGFR2 and CXCR4 by syndecan-1
- Evaluating Acetate Metabolism for Imaging and Targeting in Multiple Myeloma